Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Journal of clinical microbiology - 60(2022), 5 vom: 18. Mai, Seite e0014022 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Stanley, Sydney [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Analytical sensitivity |
|---|
| Anmerkungen: |
Date Completed 20.05.2022 Date Revised 20.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1128/jcm.00140-22 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM339694629 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM339694629 | ||
| 003 | DE-627 | ||
| 005 | 20231226003453.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1128/jcm.00140-22 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1132.xml |
| 035 | |a (DE-627)NLM339694629 | ||
| 035 | |a (NLM)35440165 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Stanley, Sydney |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.05.2022 | ||
| 500 | |a Date Revised 20.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Delta | |
| 650 | 4 | |a Omicron | |
| 650 | 4 | |a RT-qPCR | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a analytical sensitivity | |
| 650 | 4 | |a antigen test | |
| 650 | 4 | |a lateral flow assay | |
| 650 | 4 | |a limit of detection | |
| 700 | 1 | |a Hamel, Donald J |e verfasserin |4 aut | |
| 700 | 1 | |a Wolf, Ian D |e verfasserin |4 aut | |
| 700 | 1 | |a Riedel, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Dutta, Sanjucta |e verfasserin |4 aut | |
| 700 | 1 | |a Contreras, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Callahan, Cody J |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Annie |e verfasserin |4 aut | |
| 700 | 1 | |a Arnaout, Ramy |e verfasserin |4 aut | |
| 700 | 1 | |a Kirby, James E |e verfasserin |4 aut | |
| 700 | 1 | |a Kanki, Phyllis J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical microbiology |d 1975 |g 60(2022), 5 vom: 18. Mai, Seite e0014022 |w (DE-627)NLM000005460 |x 1098-660X |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2022 |g number:5 |g day:18 |g month:05 |g pages:e0014022 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1128/jcm.00140-22 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2022 |e 5 |b 18 |c 05 |h e0014022 | ||